[세계화] 화이자 지역개발

 1  [세계화] 화이자 지역개발-1
 2  [세계화] 화이자 지역개발-2
 3  [세계화] 화이자 지역개발-3
 4  [세계화] 화이자 지역개발-4
 5  [세계화] 화이자 지역개발-5
 6  [세계화] 화이자 지역개발-6
 7  [세계화] 화이자 지역개발-7
 8  [세계화] 화이자 지역개발-8
 9  [세계화] 화이자 지역개발-9
 10  [세계화] 화이자 지역개발-10
 11  [세계화] 화이자 지역개발-11
 12  [세계화] 화이자 지역개발-12
 13  [세계화] 화이자 지역개발-13
 14  [세계화] 화이자 지역개발-14
 15  [세계화] 화이자 지역개발-15
 16  [세계화] 화이자 지역개발-16
 17  [세계화] 화이자 지역개발-17
 18  [세계화] 화이자 지역개발-18
 19  [세계화] 화이자 지역개발-19
 20  [세계화] 화이자 지역개발-20
※ 미리보기 이미지는 최대 20페이지까지만 지원합니다.
  • 분야
  • 등록일
  • 페이지/형식
  • 구매가격
  • 적립금
자료 다운로드  네이버 로그인
소개글
[세계화] 화이자 지역개발에 대한 자료입니다.
목차
Index

Ⅰ. Introduction
A. Background
B. Purpose and Direction
C. Methodology

Ⅱ. Profile of Pfizer and Pfizer Korea
A. Outline of Pfizer Global
B. History of Pfizer Korea

Ⅲ. Withdrawal of Manufacturing Facilities of Pfizer Korea in Seoul
A. Framework of Analysis and its limitation
B. Global Production Network of Pfizer
C. Analysis of the Case in Seoul
1. Value Creation
2. Value Enhancement
3. Value Capture
D. Impact of the Withdrawal
E. Evaluation and Implication

Ⅳ. Pfizer and High-tech Medical Complex in Daegue
A. Outline of High-tech Medical Complex in Daegue
1. Process of Establishing High-tech Medical Complex.
2. Efforts of Daegu in the Bid for High-tech Medical Complex
3. After winning the bidding
B. Participation of Pfizer in Daegu cluster
C. Incentive Package Proposed by Daegu to Entice Enterprises
D. Impact of High-tech Medical Complex

Ⅴ. Conclusion


Appendix

본문내용
2. Value Enhancement
For value enhancement, in the view point of regional development, the result was not that successful. To enhance the created value, the knowledge and technology should be transferred to the region consistently, but most of transnational pharmaceutical companies in Korea including Pfizer have a defensive stand for that.
All pharmaceutical corporations in Korea are the member of Korea Pharmaceutical Manufacturers Association (KPMA). However, transnational pharmaceutical corporations form another association, Korean Research-based Pharmaceutical Industry Association (KRPIA) independently. KRPIA distinguishes themselves from Korean pharmaceutical corporations by emphasizing their role in research and development. These two separate association show that transnational pharmaceutical companies are close with joint research or investment with Korean companies. “외자제약 독자노선 행보 너무하다,” 인터넷신문 데일리팜, 2006. 5. 8,


Moreover, the power relationship with collective power including labor union was relatively hostile to each other. If the labour union contributes to increase of productivity through horizontal and cooperative relationship with the management, more value can be enhanced and captured. However, there has been a severe conflict between labour and management rising from personnel matters in 2003. "화이자 노사갈등, 팽팽한 긴장감 지속," 인터넷신문 데일리메디, 2003. 5. 9

"화이자도 서울공장 철수, ‘脫한국’ 신호탄," 인터넷신문 데일리메디, 2006. 4. 19

As a result, it became a barrier for value enhancement and capture.

3. Value Capture
In value capture, institutional power had a great role. Transnational